title: Serum bile acids and pruritus in hemodialysis patients.
abstract: BACKGROUND
  Chronic renal failure (CRF) patients usually suffer from pruritus. The pathophysiology of pruritus is still incompletely understood.
  
  
  METHODS
  In this paper we determined serum total bile acids (STBA) in hemodialysis patients with advanced CRF (ACRF) in order to obtain STBA concentration in predialysis, to assess their probable relation among patients with pruritus and in postdialysis using a polysulfone membrane for dialysis. STBA were determined in 49 ACRF patients with chronic hemodialysis and values were compared to 20 control subjects. Hemodialysis patients were divided in two groups: with and without pruritus. In all these patients, month of renal replacement therapy, diabetic patients, dose of dialysis (Kt/V), viral markers, serum creatinine, serum glucose, aspartate and alanine aminotransferase, alkaline phosphatase, hematocrits and albumin were determined. The intensity of itching among pruritic patients was measured by a score system: mild (M), moderate (MO) and severe (S).
  
  
  RESULTS
  No significant differences were found in patients with and without pruritus in months of renal replacement therapy, duration of dialysis or dose of dialysis (Kt/V). STBA were determined in all ACRF patients in predialysis and they showed significant differences compared to controls (p < 0.05), however, no differences were observed in the results obtained when control subjects were compared to ACRF patients without pruritus. Also in predialysis, pruritic patients showed significant differences in STBA compared to patients without pruritus (p < 0.001). STBA concentration showed a significant decrease in postdialysis using a polysulfone membrane in ACRF patients with and without pruritus. Finally, correlation with STBA and itch score of pruritus was significant (p < 0.02).
  
  
  CONCLUSIONS
  Hemodialysis patients with ACRF and pruritus showed an increase of STBA in predialysis and a decrease in postdialysis.
authors.affiliation: Hospital Aeronáutico Central, Departamento Medicina Interna, Buenos Aires, Argentina.
authors.forename: A
authors.initials: A
authors.lastname: Mamianetti
authors.forename: V
authors.initials: V
authors.lastname: Tripodi
authors.forename: C
authors.initials: C
authors.lastname: Vescina
authors.forename: D
authors.initials: D
authors.lastname: Garrido
authors.forename: N
authors.initials: N
authors.lastname: Vizioli
authors.forename: C
authors.initials: C
authors.lastname: Carducci
authors.forename: C
authors.initials: C
authors.lastname: Agost Carreño
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001647:Bile Acids and Salts / Q000097:blood*; D018450:Disease Progression; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D011537:Pruritus / Q000209:etiology*; D006435:Renal Dialysis
chemical_list: D001647:Bile Acids and Salts; D008567:Membranes, Artificial